Last $62.90 USD
Change Today -0.34 / -0.54%
Volume 1.2M
OCR On Other Exchanges
Symbol
Exchange
New York
Stuttgart
As of 8:04 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

omnicare inc (OCR) Snapshot

Open
$63.47
Previous Close
$63.24
Day High
$63.54
Day Low
$62.80
52 Week High
07/1/14 - $67.49
52 Week Low
10/23/13 - $52.26
Market Cap
6.2B
Average Volume 10 Days
946.2K
EPS TTM
$2.72
Shares Outstanding
97.9M
EX-Date
09/18/14
P/E TM
23.1x
Dividend
$0.80
Dividend Yield
1.27%
Current Stock Chart for OMNICARE INC (OCR)

omnicare inc (OCR) Related Businessweek News

View More BusinessWeek News

omnicare inc (OCR) Details

Omnicare, Inc. operates as a healthcare services company that specializes in the management of pharmaceutical care in the United States and Canada. It operates through two segments, Long-Term Care Group and Specialty Care Group. The company offers pharmaceuticals, and related pharmacy and ancillary services to long-term care facilities, as well as chronic care facilities and other settings. It also operates institutional pharmacy business serving skilled nursing facilities, assisted living facilities, independent living communities, hospitals, correctional facilities, and other healthcare service providers; and provides pharmacy consulting services, including monthly patient drug therapy evaluations, assistance in compliance with state and federal regulations, as well as offers proprietary clinical and health management programs. In addition, the company provides a suite of technology solutions based on its Omniview Web-based platform as the electronic ordering of prescription refills, proof-of-delivery tracking, and real-time validation of Medicare Part D coverage; intravenous medications and nutrition products, respiratory therapy services, and clinical care planning services; and pharmaceutical case management services for retirees, employees, and dependents. Further, it offers specialty pharmacy and commercialization services for the biopharmaceutical industry; and provides brand support services, supply chain solutions, patient support services, and specialty pharmacy platforms. The company’s specialized drugs deal primarily with specific categories of drugs and disease states, such as rheumatoid arthritis, multiple sclerosis, oncology, and growth hormones. Omnicare, Inc. was founded in 1981 and is headquartered in Cincinnati, Ohio.

13,000 Employees
Last Reported Date: 02/19/14
Founded in 1981

omnicare inc (OCR) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $924.5K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $506.2K
Senior Vice President, General Counsel and Se...
Total Annual Compensation: $485.3K
Consultant
Total Annual Compensation: $1.3M
Compensation as of Fiscal Year 2013.

omnicare inc (OCR) Key Developments

Omnicare, Inc. Declares Quarterly Cash Dividend, Payable on September 29, 2014

Omnicare Inc. announced that its Board of Directors has approved a quarterly cash dividend of $0.20 per share on the company's common stock, to be paid on September 29, 2014, to all stockholders of record on September 22, 2014.

AG Conway Announces Nearly $16.5 Million Settlement with Omnicare Inc

Attorney General Jack Conway and his Medicaid Fraud and Abuse Control Unit announced that Kentucky has joined with other states and the federal government in a $16.48 million settlement with Omnicare Inc. The settlement resolves allegations that Omnicare offered improper financial incentives to skilled nursing facilities in return for their continued selection of Omnicare to supply drugs to Medicaid recipients. Kentucky's total share of the settlement is $348,975.84. The federal government will receive $240,130.55 for its share of Kentucky-related damages. According to the settlement agreement, Omnicare entered into below-cost contracts to supply prescription medication and other pharmaceutical drugs to skilled nursing facilities and their resident patients to persuade the facilities to select Omnicare as their pharmacy provider for nursing home residents covered by Kentucky's Medicaid program. The government alleges that this conduct violated the federal Anti-Kickback Statute and resulted in the submission of false claims to the Kentucky Medicaid program. The Anti-Kickback Statute prohibits offering, paying, soliciting or receiving payment to induce referrals of items or services covered by Medicare, Medicaid and other federally funded programs. The Anti-Kickback Statute is intended to ensure that the selection of health care providers and suppliers is not compromised by improper financial incentives and is instead based on the best interests of the patient. The settlement resulted from a whistleblower lawsuit originally filed in the United States District Court for the District of New Jersey.

Omnicare Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Revised Earnings Guidance for 2014

Omnicare Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, net sales were $1,610,584,000 against $1,503,116,000 last year. Operating income was $130,246,000 against $106,680,000 last year. Income from continuing operations before income taxes was $100,266,000 against $77,056,000 last year. Income from continuing operations was $61,246,000 or $0.58 per diluted share against $47,302,000 or $0.43 per diluted share last year. Net income was $21,971,000 or $0.21 per diluted share against $52,219,000 or $0.48 per diluted share last year. Net cash flows from operating activities was $218,882,000. Capital expenditures were $21,858,000. Adjusted cash earnings per diluted share from continuing operations were $0.91 against $0.85 last year. EBITDA from continuing operations was $157,393,000 against $133,991,000 last year. Adjusted EBITDA from continuing operations was $176,224,000 against $168,771,000 last year. For the six months, net sales were $3,181,622,000 against $2,962,061,000 last year. Operating income was $262,998,000 against $215,056,000 last year. Income from continuing operations before income taxes was $203,577,000 against $155,970,000 last year. Income from continuing operations was $124,884,000 or $1.17 per diluted share against $95,616,000 or $0.88 per diluted share last year. Net income was $85,745,000 or $0.80 per diluted share against $106,573,000 or $0.98 per diluted share last year. Net cash flows from operating activities was $396,380,000. Capital expenditures were $48,023,000. Adjusted cash earnings per diluted share from continuing operations were $1.82 against $1.69 last year. EBITDA from continuing operations was $317,750,000 against $268,287,000 last year. Adjusted EBITDA from continuing operations was $353,909,000 against $329,692,000 last year. Based upon its first half results, Omnicare updated its expectations for cash flows and reaffirmed other elements of its full year of 2014 guidance. The company expects revenue in the range of $6.3 billion to $6.4 billion against previous revenue guidance in the range of $6.3 billion to $6.4 billion. Adjusted cash earnings per diluted share (excluding special items) are expected to be in the range of $3.64 to $3.72 against previous guidance in the range of $3.64 to $3.72. Cash flows from operations (excluding settlement payments) is expected to be in the range of $500 million to $550 million against previous guidance in the range of $475 million to $550 million.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCR:US $62.90 USD -0.34

OCR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cintas Corp $67.16 USD -0.055
Covance Inc $85.49 USD -0.42
Envision Healthcare Holdings Inc $36.53 USD +0.03
Patterson Cos Inc $40.65 USD -0.30
WESCO International Inc $82.75 USD -0.16
View Industry Companies
 

Industry Analysis

OCR

Industry Average

Valuation OCR Industry Range
Price/Earnings 54.8x
Price/Sales 1.0x
Price/Book 2.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OMNICARE INC, please visit www.omnicare.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.